Ultrasensitive biosensor based on MXene-GO field-effect transistor for the rapid detection of endotoxin and

Hale Alvandi1, Farina Asadi1, Ali Hossein Rezayan1

  • 1Department of Nanobiotechnology and Biomimetics, School of Bioengineering, College of Interdisciplinary Science and Technology, University of Tehran, Tehran, Iran.

PubMed
Abstract

Insights

A novel MXene-GO-Apt FET biosensor offers rapid and sensitive detection of E. coli and its endotoxin, crucial for diagnosing sepsis. This Field-effect-Transistor aptasensor provides a potential point-of-care solution for pathogen detection.

Area of Science:

  • Nanotechnology
  • Biosensors
  • Materials Science

Background:

  • Sepsis affects over 30 million people annually, posing a significant global health challenge.
  • Current sepsis diagnosis is hindered by similar clinical symptoms and lack of specific tests.
  • Fast and accurate detection of pathogens like E. coli is essential for effective sepsis management.

Purpose of the Study:

  • To design and fabricate a Field-effect-Transistor aptasensor (MXene-GO-Apt FET) for detecting E. coli and its endotoxin (lipopolysaccharide).
  • To evaluate the biosensor's sensitivity, selectivity, stability, and performance in biological samples.

Main Methods:

  • Preparation of MXene and its composite with graphene oxide (GO).
  • Immobilization of amino ssDNA aptamer on the MXene-GO composite surface.
  • Fabrication of the Field-effect-Transistor aptasensor and characterization of its electrical properties.

Main Results:

  • The MXene-GO composite provided stable electrical conductivity for the biosensor.
  • The MXene-GO-Apt FET demonstrated high selectivity for E. coli and lipopolysaccharide.
  • Achieved detection limits of 1 pg/ml for lipopolysaccharide and 3 CFU/ml for E. coli in PBS buffer.
  • The biosensor maintained stability for 30 days and detected endotoxin and E. coli in human blood serum within 300 seconds.

Conclusions:

  • The developed MXene-GO-Apt FET nanobiosensor enables rapid, accurate, and ultrasensitive detection of E. coli and its endotoxin.
  • The biosensor requires a small sample volume and can be operated by unskilled users.
  • This technology holds promise as a point-of-care sensor for timely pathogen detection in sepsis patients.